These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 27124920)
1. Can We Identify Nephrogenic Adenoma in Urine Cytology Specimens? A Study Evaluating Previously Described Cytomorphologic Features in Correlation With PAX8 Immunohistochemical Staining Results. McCroskey Z; Pambuccian SE; Wojcik EM; Barkan GA Am J Clin Pathol; 2016 Mar; 145(3):373-8. PubMed ID: 27124920 [TBL] [Abstract][Full Text] [Related]
3. Flat pattern of nephrogenic adenoma: previously unrecognized pattern unveiled using PAX2 and PAX8 immunohistochemistry. Piña-Oviedo S; Shen SS; Truong LD; Ayala AG; Ro JY Mod Pathol; 2013 Jun; 26(6):792-8. PubMed ID: 23328975 [TBL] [Abstract][Full Text] [Related]
4. Expression of PAX8 in nephrogenic adenoma and clear cell adenocarcinoma of the lower urinary tract: evidence of related histogenesis? Tong GX; Weeden EM; Hamele-Bena D; Huan Y; Unger P; Memeo L; O'Toole K Am J Surg Pathol; 2008 Sep; 32(9):1380-7. PubMed ID: 18670350 [TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical staining characteristics of nephrogenic adenoma using the PIN-4 cocktail (p63, AMACR, and CK903) and GATA-3. McDaniel AS; Chinnaiyan AM; Siddiqui J; McKenney JK; Mehra R Am J Surg Pathol; 2014 Dec; 38(12):1664-71. PubMed ID: 24921643 [TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical markers for the differential diagnosis of nephrogenic adenomas. Quinones W; Ziober A; Yao Y; Bing Z Ann Diagn Pathol; 2013 Feb; 17(1):41-4. PubMed ID: 22672805 [TBL] [Abstract][Full Text] [Related]
7. Utility of paired box gene 8 (PAX8) expression in fluid and fine-needle aspiration cytology: an immunohistochemical study of metastatic ovarian serous carcinoma. McKnight R; Cohen C; Siddiqui MT Cancer Cytopathol; 2010 Oct; 118(5):298-302. PubMed ID: 20572292 [TBL] [Abstract][Full Text] [Related]
8. Nephrogenic adenoma of the urinary tract: a review. Alexiev BA; LeVea CM Int J Surg Pathol; 2012 Apr; 20(2):123-31. PubMed ID: 22415059 [TBL] [Abstract][Full Text] [Related]
9. BK polyomavirus-infected nephrogenic adenoma of the urinary bladder in a renal transplant recipient: A case report. Alexiev BA; Papadimitriou JC; Drachenberg CB Pathol Res Pract; 2015 Sep; 211(9):697-701. PubMed ID: 26189101 [TBL] [Abstract][Full Text] [Related]
10. PAX8 positivity in nested variant of urothelial carcinoma: a potential diagnostic pitfall. Legesse T; Matoso A; Epstein JI Hum Pathol; 2019 Dec; 94():11-15. PubMed ID: 31669177 [TBL] [Abstract][Full Text] [Related]
11. Utility of PAX8 and PAX2 immunohistochemistry in the identification of renal cell carcinoma in diagnostic cytology. Knoepp SM; Kunju LP; Roh MH Diagn Cytopathol; 2012 Aug; 40(8):667-72. PubMed ID: 22807381 [TBL] [Abstract][Full Text] [Related]
12. PAX8: a sensitive and specific marker to identify cancer cells of ovarian origin for patients prior to neoadjuvant chemotherapy. Wang Y; Wang Y; Li J; Yuan Z; Yuan B; Zhang T; Cragun JM; Kong B; Zheng W J Hematol Oncol; 2013 Aug; 6():60. PubMed ID: 23958394 [TBL] [Abstract][Full Text] [Related]
13. PAX8 is expressed in anaplastic thyroid carcinoma diagnosed by fine-needle aspiration: a study of three cases with histological correlates. Bellevicine C; Iaccarino A; Malapelle U; Sasso FC; Biondi B; Troncone G Eur J Endocrinol; 2013 Sep; 169(3):307-11. PubMed ID: 23811186 [TBL] [Abstract][Full Text] [Related]
14. Nephrogenic adenoma identified on urine cytology using PAX-2 immunostaining. Herlitz LC; Tong GX; Hamele-Bena D; Greenebaum E Diagn Cytopathol; 2008 Jan; 36(1):47-9. PubMed ID: 18064687 [TBL] [Abstract][Full Text] [Related]
15. A comprehensive analysis of PAX8 expression in human epithelial tumors. Laury AR; Perets R; Piao H; Krane JF; Barletta JA; French C; Chirieac LR; Lis R; Loda M; Hornick JL; Drapkin R; Hirsch MS Am J Surg Pathol; 2011 Jun; 35(6):816-26. PubMed ID: 21552115 [TBL] [Abstract][Full Text] [Related]
16. Pax8 as a useful adjunct marker to differentiate pancreatic serous cystadenoma from clear cell renal cell carcinoma in both cytologic and surgical specimens. Chi Z; Xu J; Karamchandani DM; Peng L Diagn Pathol; 2023 Apr; 18(1):54. PubMed ID: 37098593 [TBL] [Abstract][Full Text] [Related]
17. The role of GATA binding protein 3 in the differential diagnosis of collecting duct and upper tract urothelial carcinomas. Gonzalez-Roibon N; Albadine R; Sharma R; Faraj SF; Illei PB; Argani P; Ertoy D; Allaf ME; Netto GJ Hum Pathol; 2013 Dec; 44(12):2651-7. PubMed ID: 24071011 [TBL] [Abstract][Full Text] [Related]
18. Lymphoid Enhancer Binding Factor 1 (LEF1) and Paired Box Gene 8 (PAX8): A Limited Immunohistochemistry Panel to Distinguish Solid Pseudopapillary Neoplasms and Pancreatic Neuroendocrine Tumors. Lu H; Allende D; Liu X; Zhang Y Appl Immunohistochem Mol Morphol; 2020; 28(10):776-780. PubMed ID: 32723981 [TBL] [Abstract][Full Text] [Related]
19. Does subdivision of the "atypical" urine cytology increase predictive accuracy for urothelial carcinoma? Bostwick DG; Hossain D Diagn Cytopathol; 2014 Dec; 42(12):1034-44. PubMed ID: 24838797 [TBL] [Abstract][Full Text] [Related]
20. ProEx C as an adjunct marker to improve cytological detection of urothelial carcinoma in urinary specimens. Moatamed NA; Rao JY; Alexanian S; Cobarrubias M; Levin M; Lu D; Apple SK Cancer Cytopathol; 2013 Jun; 121(6):320-8. PubMed ID: 23364848 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]